The study, published in the Global Spine Journal, assessed Carlsmed’s personalized interbody spacers with traditional implants. Sixty-five patients were assessed, and researchers found that using personalized spinal devices led to “significant improvement” in achieving pelvic incidence and lumbar lordosis alignments.
“In the publication, data is provided indicating that utilization of Aprevo patient-specific devices resulted in a 42% improvement in achieving PI-LL mismatch within 5 degrees of the surgeons’ preoperative plans,” lead author Justin Smith, MD, PhD, said in a news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
